CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 764 entries

View as:

Wear and Migration in the Corin Mini-Hip/Metafix and ECIMA Polyethylene

Phase: N/A Priority: Normal

NCT ID: NCT02174965 Org: User:

Start: 09/30/12 End: 09/30/22 Due: 09/30/23

Effects of a Brief Mental Exercise on Emotional Processing

Phase: N/A Priority: Normal

NCT ID: NCT03698175 Org: User:

Start: 05/24/17 End: 10/10/18 Due: 10/10/19

Pilot Study of Deep Brain Stimulation for Severe Anorexia Nervosa

Phase: N/A Priority: Normal

NCT ID: NCT01924598 Org: User:

Start: 07/31/13 End: 06/30/25 Due: 06/30/26

Observational Study of Immune Response to Hepatitis B Childhood Booster

Phase: N/A Priority: Normal

NCT ID: NCT00873652 Org: User:

Start: 02/28/09 End: 01/31/11 Due: 01/31/12

Vaccines Against Salmonella Typhi

Phase: N/A Priority: Normal

NCT ID: NCT02324751 Org: User:

Start: 09/30/15 End: 06/27/22 Due: 06/27/23

A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG

Phase: N/A Priority: Normal

NCT ID: NCT00465465 Org: User:

Start: 10/31/05 End: 09/30/07 Due: 09/30/08

Evaluation of a Digital Microscope for Malaria

Phase: N/A Priority: Normal

NCT ID: NCT03512678 Org: User:

Start: 06/25/18 End: 06/30/20 Due: 06/30/21

Study of Controlled Human Plasmodium Vivax Infection

Phase: N/A Priority: Normal

NCT ID: NCT03377296 Org: User:

Start: 03/03/18 End: 04/13/23 Due: 04/13/24

A Study of Cardiovascular Events iN Diabetes Plus

Phase: N/A Priority: Normal

NCT ID: NCT05441267 Org: User:

Start: 03/13/23 End: 08/17/48 Due: 08/17/49

The Impact of C-reactive Protein Testing

Phase: N/A Priority: Normal

NCT ID: NCT02758821 Org: User:

Start: 06/08/16 End: 09/30/17 Due: 09/30/18

Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.

Phase: N/A Priority: Normal

NCT ID: NCT04271306 Org: User:

Start: 05/25/21 End: 02/19/24 Due: 02/19/25

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Phase: N/A Priority: Normal

NCT ID: NCT05571735 Org: User:

Start: 04/15/23 End: 12/31/25 Due: 12/31/26

Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP

Phase: N/A Priority: Normal

NCT ID: NCT01142765 Org: User:

Start: 06/30/10 End: 03/31/11 Due: 03/31/12

Meniscal Tear and Osteoarthritis Risk (MenTOR)

Phase: N/A Priority: Normal

NCT ID: NCT02684864 Org: User:

Start: 03/31/16 End: 02/28/26 Due: 02/28/27

Nitrous Oxide and EMOtional Cognition

Phase: N/A Priority: Normal

NCT ID: NCT06557642 Org: User:

Start: 07/10/24 End: 10/01/25 Due: 10/01/26

Giant Cell Arteritis: Improving Use of Ultrasound Evaluation

Phase: N/A Priority: Normal

NCT ID: NCT02523625 Org: User:

Start: 10/31/15 End: 06/30/18 Due: 06/30/19

Pictorial Representation of Illness and Self Measure

Phase: N/A Priority: Normal

NCT ID: NCT01707186 Org: User:

Start: 10/18/12 End: 06/30/18 Due: 06/30/19

Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria

Phase: N/A Priority: Normal

NCT ID: NCT01641289 Org: User:

Start: 07/10/12 End: 09/21/14 Due: 09/21/15

Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy

Phase: N/A Priority: Normal

NCT ID: NCT01243398 Org: User:

Start: 03/31/09 End: 05/31/12 Due: 05/31/13

The Effect of Losartan on Emotional Processing in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT03434054 Org: User:

Start: 06/01/16 End: 06/30/17 Due: 06/30/18

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Phase: N/A Priority: Normal

NCT ID: NCT05648448 Org: User:

Start: 02/22/23 End: 01/01/27 Due: 01/01/28

COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection

Phase: N/A Priority: Normal

NCT ID: NCT04444674 Org: User:

Start: 06/24/20 End: 12/31/21 Due: 12/31/22

Neural Effects of Cognitive-behaviour Therapy in Panic Disorder

Phase: N/A Priority: Normal

NCT ID: NCT03251235 Org: User:

Start: 01/01/11 End: 02/01/16 Due: 02/01/17

Capturing MultiORgan Effects of COVID-19

Phase: N/A Priority: Normal

NCT ID: NCT04510025 Org: User:

Start: 05/13/20 End: 05/01/26 Due: 05/01/27

Mass Vaccine and Drug Administration, Bangladesh

Phase: N/A Priority: Normal

NCT ID: NCT06068530 Org: User:

Start: 02/15/25 End: 02/01/28 Due: 02/01/29

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Wear and Migration in the Corin Mini-Hip/Metafix and ECIMA Polyethylene	NCT02174965	University of Oxford	user2@example.com	None	2012-09-30	2022-09-30	2023-09-30	-	-	2025-07-14
Effects of a Brief Mental Exercise on Emotional Processing	NCT03698175	University of Oxford	user2@example.com	None	2017-05-24	2018-10-10	2019-10-10	-	-	2025-07-14
Pilot Study of Deep Brain Stimulation for Severe Anorexia Nervosa	NCT01924598	University of Oxford	user2@example.com	None	2013-07-31	2025-06-30	2026-06-30	-	-	2025-07-14
Observational Study of Immune Response to Hepatitis B Childhood Booster	NCT00873652	University of Oxford	user2@example.com	None	2009-02-28	2011-01-31	2012-01-31	-	-	2025-07-14
Vaccines Against Salmonella Typhi	NCT02324751	University of Oxford	user2@example.com	None	2015-09-30	2022-06-27	2023-06-27	-	-	2025-07-14
A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG	NCT00465465	University of Oxford	user2@example.com	None	2005-10-31	2007-09-30	2008-09-30	-	-	2025-07-14
Evaluation of a Digital Microscope for Malaria	NCT03512678	University of Oxford	user2@example.com	None	2018-06-25	2020-06-30	2021-06-30	-	-	2025-07-14
Study of Controlled Human Plasmodium Vivax Infection	NCT03377296	University of Oxford	user2@example.com	None	2018-03-03	2023-04-13	2024-04-13	-	-	2025-07-14
A Study of Cardiovascular Events iN Diabetes Plus	NCT05441267	University of Oxford	user2@example.com	None	2023-03-13	2048-08-17	2049-08-17	-	-	2025-07-14
The Impact of C-reactive Protein Testing	NCT02758821	University of Oxford	user2@example.com	None	2016-06-08	2017-09-30	2018-09-30	-	-	2025-07-14
Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.	NCT04271306	University of Oxford	user2@example.com	None	2021-05-25	2024-02-19	2025-02-19	-	-	2025-07-14
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients	NCT05571735	University of Oxford	user2@example.com	None	2023-04-15	2025-12-31	2026-12-31	-	-	2025-07-14
Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP	NCT01142765	University of Oxford	user2@example.com	None	2010-06-30	2011-03-31	2012-03-31	-	-	2025-07-14
Meniscal Tear and Osteoarthritis Risk (MenTOR)	NCT02684864	University of Oxford	user2@example.com	None	2016-03-31	2026-02-28	2027-02-28	-	-	2025-07-14
Nitrous Oxide and EMOtional Cognition	NCT06557642	University of Oxford	user2@example.com	None	2024-07-10	2025-10-01	2026-10-01	-	-	2025-07-14
Giant Cell Arteritis: Improving Use of Ultrasound Evaluation	NCT02523625	University of Oxford	user2@example.com	None	2015-10-31	2018-06-30	2019-06-30	-	-	2025-07-14
Pictorial Representation of Illness and Self Measure	NCT01707186	University of Oxford	user2@example.com	None	2012-10-18	2018-06-30	2019-06-30	-	-	2025-07-14
Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria	NCT01641289	University of Oxford	user2@example.com	None	2012-07-10	2014-09-21	2015-09-21	-	-	2025-07-14
Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy	NCT01243398	University of Oxford	user2@example.com	None	2009-03-31	2012-05-31	2013-05-31	-	-	2025-07-14
The Effect of Losartan on Emotional Processing in Healthy Volunteers	NCT03434054	University of Oxford	user2@example.com	None	2016-06-01	2017-06-30	2018-06-30	-	-	2025-07-14
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza	NCT05648448	University of Oxford	user2@example.com	None	2023-02-22	2027-01-01	2028-01-01	-	-	2025-07-14
COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection	NCT04444674	University of Oxford	user2@example.com	None	2020-06-24	2021-12-31	2022-12-31	-	-	2025-07-14
Neural Effects of Cognitive-behaviour Therapy in Panic Disorder	NCT03251235	University of Oxford	user2@example.com	None	2011-01-01	2016-02-01	2017-02-01	-	-	2025-07-14
Capturing MultiORgan Effects of COVID-19	NCT04510025	University of Oxford	user2@example.com	None	2020-05-13	2026-05-01	2027-05-01	-	-	2025-07-14
Mass Vaccine and Drug Administration, Bangladesh	NCT06068530	University of Oxford	user2@example.com	None	2025-02-15	2028-02-01	2029-02-01	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance